NASDAQ
ArriVent BioPharma, Inc. Common Stock (AVBP) has a market cap of $1.22B as of Thursday, May 21, 2026. The AVBP market cap is up 2.12% over the past 30 days and has grown 75.36% over the past year. Market capitalization represents the total market value of a company's outstanding shares, calculated by multiplying the stock price by the total number of shares outstanding.
No price data available for this timeframe.